Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
29.8M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
6.48M
-
Shares change
-
+821K
-
Total reported value, excl. options
-
$13.7M
-
Value change
-
+$1.72M
-
Number of buys
-
6
-
Number of sells
-
-5
-
Price
-
$2.11
Significant Holders of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) as of Q2 2025
16 filings reported holding SNTI - Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.48M shares
of 29.8M outstanding shares and own 21.77% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (3.78M shares), ARMISTICE CAPITAL, LLC (892K shares), Nantahala Capital Management, LLC (888K shares), HEIGHTS CAPITAL MANAGEMENT, INC (381K shares), VANGUARD GROUP INC (361K shares), GEODE CAPITAL MANAGEMENT, LLC (147K shares), BlackRock, Inc. (22.1K shares), STATE STREET CORP (10K shares), UBS Group AG (4.41K shares), and Tower Research Capital LLC (TRC) (1.12K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.